Neurobehavioural Screening, Microfabricated Platforms and Medical Device Innovation with Microfluidics
Posted 10th December 2018 by Kieran Chambers
Microfluidics is revolutionising the way patients are diagnosed, monitored and treated. If you weren’t able to attend the 4BIO Summit in San Francisco, we have made these presentation slides from Suvajyoti Guha, Dr Todd Thorsen & Pouya Rezai available here.
Lipids versus hepatic inflammation: a lysosomal interplay
Posted 7th December 2018 by Kieran Chambers
The consumption of a healthy diet in combination with regular physical exercise is essential for an optimal and healthy condition, keeping the body in good shape. Although dietary guidelines may help in defining what is a healthy diet, the term healthy not only depends on individual needs and/or opinions.
How to cope with an evolving Immuno-Oncology field and changes in pathology
Posted 5th December 2018 by Kieran Chambers
2018 will be remembered as a decisive year for immuno-oncology. In particular, Nobel Prize winners James Allison of MD Anderson Cancer Center in Houston, Texas, and Tasuku Honjo of Kyoto University in Japan lifted the field of immunotherapy to international recognition for those outside the scientific and medical communities. For the patient, these new alternatives to standard oncology therapies offer new hope for life-extending treatments using immunotherapy.
Is Not Dying Yet on your bucket list?
Posted 30th November 2018 by Kieran Chambers
The Fatty Liver Foundation exists because I was not willing to be a well behaved member of the parade of misery that liver disease is becoming for our society. My bucket list includes not dying of liver disease.
A personal translation of Microbiome Futures
Posted 28th November 2018 by Jane Williams
It was a pleasure to have Dirk Gevers involved in our Microbiome Futures project earlier this year. In the following opinion piece, Dirk reflects on the outcomes that went on to be published in Nature Biotechnology.
The original article can be found on Biovox and is republished here with kind permission.
Tuning Algorithms to the Histology Lab
Posted 26th November 2018 by Kieran Chambers
The promise of an effective set of tools based on deep learning or other machine learning algorithms is the current buzz of the digital pathology markets. While the evolving tools, models and techniques are producing strongly positive results, there are still many factors which impact the utility and portability of models and tools being created across real-world data sets.
DNA is no longer just ACGT: synthetic DNA is here to stay
Posted 23rd November 2018 by Kieran Chambers
One of the most amazing aspects surrounding us is life itself – not just humans, but the environment: trees, flowers, insects, animals and even bacteria. They all share one central molecule which is crucial for their existence.
Ten things you need to know about going 100% digital for primary histopathology diagnosis
Posted 21st November 2018 by Kieran Chambers
Digital pathology is based on creating a digital replica of the glass slide, called whole slide image (WSI). This image is then viewed in a computer screen, which eliminates the need for using a microscope. Can you imagine working in a glassless environment, with better ergonomics and being able to immediately find the slide you need?
